# A Study to Learn About How Loss of Liver Function Affects the Blood Levels of the Study Medicine Called PF-07817883.

> **NCT05884554** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 21 (actual)

## Conditions studied

- COVID-19

## Interventions

- **DRUG:** PF-07817883

## Key facts

- **NCT ID:** NCT05884554
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-06-15
- **Primary completion:** 2024-06-27
- **Final completion:** 2024-06-27
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2024-09-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05884554

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05884554, "A Study to Learn About How Loss of Liver Function Affects the Blood Levels of the Study Medicine Called PF-07817883.". Retrieved via AI Analytics 2026-08-17 from https://api.ai-analytics.org/clinical/NCT05884554. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*